2000
DOI: 10.1007/s004499900068
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of rifamycin B production using mutant strains of Amycolatopsis mediterranei

Abstract: Two mutant strains of Amycolatopsis mediterranei VA17 and VA18 were isolated using physical (UV) and chemical (NTG) mutagens gave high rifamycin B than the parent type when grown in the same fermentation medium with a pH of 7.2, temperature 32°C for a period of 12 days. The cultural conditions of both mutant strains are similar to the parent strain except temperature which was higher by 4°C. By this mutation and selection study, rifamycin B production was improved from 1400 mg/l to 2450 mg/l.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 13 publications
0
9
0
Order By: Relevance
“…Complete knowledge of optimal conditions required for maximum fermentation activity leading to antimicrobial metabolite production by actinomycetes is required so as to standardize the different physical and physiological factors influencing the production of metabolites with antibiotic properties with particular reference to the strain used [6]. The present article deals with isolation of actinomycete strains from the marine soil samples collected from Palk Strait, East Coast of India and characterization of potent strains capable of synthesizing novel antimicrobial compounds, determination of the superior strain at species level and optimization of conditions required for the production of antimicrobial compound.…”
Section: Introductionmentioning
confidence: 99%
“…Complete knowledge of optimal conditions required for maximum fermentation activity leading to antimicrobial metabolite production by actinomycetes is required so as to standardize the different physical and physiological factors influencing the production of metabolites with antibiotic properties with particular reference to the strain used [6]. The present article deals with isolation of actinomycete strains from the marine soil samples collected from Palk Strait, East Coast of India and characterization of potent strains capable of synthesizing novel antimicrobial compounds, determination of the superior strain at species level and optimization of conditions required for the production of antimicrobial compound.…”
Section: Introductionmentioning
confidence: 99%
“…The reported yields of Rifamycin B are 2.45 g L À1 in 12 days with barbital using Amycolatopsis mediterranei VA18 strain (Venkateswarlu et al, 2000) and 2.20 g L À1 without bar- bital using Amycolatopsis mediterranei ATCC 21789 strain (Richard and Lancini, 1975). We used the Amycolatopsis mediterranei S699 strain that does not require barbital (Yu et al, 2001).…”
Section: Resultsmentioning
confidence: 97%
“…The parameter range for the medium component was selected based on previous reports (Kim et al, 1996;Richard and Lancini, 1975;Sensi and Thiemann, 1967;Venkateswarlu et al, 2000) as follows:…”
Section: Medium Componentsmentioning
confidence: 99%
“…Scaling up and optimization of antibiotic production in the fermentor necessitates studying influences of different physical and physiological factors affecting its production; taking into concern that the optimal fermentation conditions are related to the strain used [9]. Fed-batch addition of 5% glucose syrup at day 3 or day 4 gives almost the same yield (17-17.5 g/l) and even further addition of 5% glucose syrup at day 7 decreased the yield to 14.9 g/l.…”
Section: Discussionmentioning
confidence: 99%